2025.12.08
Perfolio Update: 30 Newly-Published Patents Added
License-In
We have added 30 newly-published patent applications to our iPS cell technology patent portfolio. Please refer to the link below for the details of each application.
AJ264 Cell purification method
AJ271 Drug for treating or preventing charcot-marie-tooth disease
AJ272 Therapeutic or prophylactic medicine for fragile x syndrome
AJ273 Production method for renal collecting duct cells and pelvic epithelial cells
AJ275 SARS-CoV-2-derived polynucleotide and use thereof
AJ277 Epicardial cell regeneration promoter and method for promoting epicardial cell regeneration
AJ279 Thymic epithelial cell production method
AJ280 In vitro culturing method for inducing ovarian follicles from fetal ovarian cells of primate
AJ281 Axioloid: a stem cell-based model of human axial development
AJ282 Method for producing respiratory organoids
AJ283 Mutant oct3/4 protein, and method for producing induced pluripotent stem cells
AJ284 Mutant KLF protein, and method for producing induced pluripotent stem cells
AJ285 Immune cell induced from iPS cell
AJ286 Method for producing small intestine tissue
AJ287 Method for producing mature cardiomyocytes
AJ288 Method for producing hepatocytes
AJ289 Method for producing primed pluripotent stem cells
AJ290 Method for producing naïve pluripotent stem cells
AJ292 Method for producing pancreatic endoderm cells
AJ293 CrRNA having modified nucleotide
AJ294 Method for producing mature epicardial cell
AJ295 Method for producing neural crest cells
AJ296 Target-molecule-specific functional protein control system
AJ297 Axioloid-based modular bottom-up in vitro model of human post-gastrulation development
AJ298 Prophylactic drug/therapeutic drug for progressive supranuclear palsy
Please note that information on unpublished patent applications is not disclosed. Once officially published, details will be posted on "News" or the "Patent Portfolio" page.